Atlas Trials

Investigating a Marijuana-based Compound as a Treatment for Anxiety in Autistic Adults

Clinical trial NCT06526208 · RECRUITING

Trial details

NCT number
NCT06526208
Sponsor
Southwest Autism Research & Resource Center
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Autism Spectrum DisorderAnxiety
Start date
2025-05-28
Primary completion
2026-09-30
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.